• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于检测血脑屏障中药物外排转运蛋白活性的荧光筛选测定法。

A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier.

作者信息

Bachmeier Corbin J, Miller Donald W

机构信息

Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA.

出版信息

Pharm Res. 2005 Jan;22(1):113-21. doi: 10.1007/s11095-004-9016-0.

DOI:10.1007/s11095-004-9016-0
PMID:15771237
Abstract

PURPOSE

To examine the capability of a fluorometric assay to identify and characterize the drug efflux interactions of a broad spectrum of drug agents in an in vitro model of the blood-brain barrier (BBB).

METHODS

Various concentrations of drug agent (1, 10, and 100 microM) were evaluated for their effect on the cellular accumulation of the P-glycoprotein (P-gp) probe R123 (3.2 microM), and the mixed P-gp and multidrug resistance-associated protein (MRP) probe, BCECF (1 microM), in bovine brain microvessel endothelial cell (BBMEC) monolayers. Drugs demonstrating a significant effect were further quantitated using an expanded concentration range and a nonlinear regression curve fit to determine the potency (IC50) and efficacy (Imax) of the drug for P-gp and/or MRP.

RESULTS

Several of the 36 therapeutic agents examined showed drug efflux transporter interactions in BBMEC monlayers. Melphalan and risperidone significantly enhanced the accumulation of R123 over control (1.47- and 1.82-fold, respectively) with resulting IC50s of 1.4 and 14.6 microM, respectively. Chlorambucil and valproic acid significantly enhanced the accumulation of BCECF compared to control monolayers (2.02- and 4.01-fold, respectively) with resulting IC50s of 146.1 and 768.5 microM, respectively.

CONCLUSIONS

The current study demonstrates the feasibility of a fluorometric assay consisting of R123 and BCECF in assessing the drug efflux interactions of a variety of drugs in the BBB.

摘要

目的

在血脑屏障(BBB)的体外模型中,研究一种荧光测定法识别和表征广谱药物的药物外排相互作用的能力。

方法

评估不同浓度的药物制剂(1、10和100微摩尔)对牛脑微血管内皮细胞(BBMEC)单层中P-糖蛋白(P-gp)探针R123(3.2微摩尔)和P-gp与多药耐药相关蛋白(MRP)混合探针BCECF(1微摩尔)细胞积累的影响。对显示出显著影响的药物,使用扩展的浓度范围和非线性回归曲线拟合进一步定量,以确定该药物对P-gp和/或MRP的效力(IC50)和功效(Imax)。

结果

所检测 的36种治疗药物中有几种在BBMEC单层中显示出药物外排转运体相互作用。美法仑和利培酮使R123的积累量比对照组显著增加(分别为1.47倍和1.82倍),IC50分别为1.4和14.6微摩尔。与对照单层相比,苯丁酸氮芥和丙戊酸使BCECF的积累量显著增加(分别为2.02倍和4.01倍),IC50分别为146.1和768.5微摩尔。

结论

本研究证明了由R123和BCECF组成的荧光测定法在评估BBB中多种药物的药物外排相互作用方面的可行性。

相似文献

1
A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier.一种用于检测血脑屏障中药物外排转运蛋白活性的荧光筛选测定法。
Pharm Res. 2005 Jan;22(1):113-21. doi: 10.1007/s11095-004-9016-0.
2
Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.HIV-1蛋白酶抑制剂与血脑屏障中药物外排转运体相互作用的定量评估。
Pharm Res. 2005 Aug;22(8):1259-68. doi: 10.1007/s11095-005-5271-y. Epub 2005 Aug 3.
3
Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.评价达非那新在血脑和血眼屏障的细胞培养模型中的药物外排转运体的负债情况。
Neurourol Urodyn. 2011 Nov;30(8):1633-8. doi: 10.1002/nau.21110. Epub 2011 Aug 8.
4
Comparison of drug efflux transport kinetics in various blood-brain barrier models.不同血脑屏障模型中药物外排转运动力学的比较。
Drug Metab Dispos. 2006 Jun;34(6):998-1003. doi: 10.1124/dmd.105.006999. Epub 2006 Mar 22.
5
Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.普朗尼克P85可增加极化的脑微血管内皮细胞(BBMEC)和Caco-2细胞单层中多种药物的通透性。
Pharm Res. 1999 Sep;16(9):1366-72. doi: 10.1023/a:1018990706838.
6
Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells.
Biochem Biophys Res Commun. 1998 Feb 24;243(3):816-20. doi: 10.1006/bbrc.1997.8132.
7
Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption.普朗尼克嵌段共聚物与脑微血管内皮细胞的相互作用:药物吸收的两种潜在途径的证据。
Bioconjug Chem. 1997 Sep-Oct;8(5):649-57. doi: 10.1021/bc970118d.
8
Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers.使用罗丹明123检测原代培养的脑微血管内皮细胞单层中P-糖蛋白的功能活性。
Life Sci. 1996;59(18):1521-31. doi: 10.1016/0024-3205(96)00483-3.
9
Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells.普朗尼克P85单分子和胶束对极化脑微血管内皮细胞(BBMEC)和Caco-2细胞中药物通透性的影响。
Pharm Res. 1998 Oct;15(10):1525-32. doi: 10.1023/a:1011942814300.
10
Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.血脑屏障(BBB)的药物蛋白组学:基于 BBB 转运蛋白浓度、体外内在转运活性以及在小鼠血浆和脑中的未结合分数,重建 11 种 P 糖蛋白底物的体内脑分布。
J Pharmacol Exp Ther. 2011 Nov;339(2):579-88. doi: 10.1124/jpet.111.184200. Epub 2011 Aug 9.

引用本文的文献

1
In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2.体外评估抗癫痫药物对 ABC 转运蛋白表达和功能的影响及其与 ABCC2 的相互作用。
Molecules. 2017 Sep 29;22(10):1484. doi: 10.3390/molecules22101484.
2
Nanoscale drug delivery systems and the blood-brain barrier.纳米级药物递送系统与血脑屏障。
Int J Nanomedicine. 2014 Feb 7;9:795-811. doi: 10.2147/IJN.S52236. eCollection 2014.
3
Olomoucine II, but not purvalanol A, is transported by breast cancer resistance protein (ABCG2) and P-glycoprotein (ABCB1).

本文引用的文献

1
Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells.多药耐药相关蛋白同源物在脑毛细血管内皮细胞中的质膜定位
J Pharmacol Exp Ther. 2004 Nov;311(2):449-55. doi: 10.1124/jpet.104.068528. Epub 2004 Jun 24.
2
Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport.牛脑微血管内皮细胞对丙戊酸的摄取:主动外排转运的作用
Epilepsy Res. 2004 Jan;58(1):53-66. doi: 10.1016/j.eplepsyres.2003.12.008.
3
Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF.
奥洛莫星 II,而非普伐他汀 A,可被乳腺癌耐药蛋白(ABCG2)和 P-糖蛋白(ABCB1)转运。
PLoS One. 2013 Oct 8;8(10):e75520. doi: 10.1371/journal.pone.0075520. eCollection 2013.
4
Quantitative fluorescence microscopy provides high resolution imaging of passive diffusion and P-gp mediated efflux at the in vivo blood-brain barrier.定量荧光显微镜可对活体血脑屏障中的被动扩散和 P-糖蛋白介导的外排进行高分辨率成像。
J Neurosci Methods. 2013 Sep 30;219(1):188-95. doi: 10.1016/j.jneumeth.2013.07.001. Epub 2013 Aug 2.
5
Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.苯甲酮型多药转运蛋白 P-糖蛋白抑制剂的构效关系、配体效率和脂水效率特征。
J Med Chem. 2012 Apr 12;55(7):3261-73. doi: 10.1021/jm201705f. Epub 2012 Mar 27.
6
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance protein.18F 标记的氟拉西达作为 P-糖蛋白和乳腺癌耐药蛋白正电子发射断层扫描示踪剂的放射合成与体内评价。
Bioorg Med Chem. 2011 Apr 1;19(7):2190-8. doi: 10.1016/j.bmc.2011.02.039. Epub 2011 Feb 26.
7
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.抗精神病药物作为多药耐药转运蛋白P-糖蛋白抑制剂的评估。
Psychopharmacology (Berl). 2006 Sep;187(4):415-23. doi: 10.1007/s00213-006-0437-9. Epub 2006 Jun 30.
8
Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.HIV-1蛋白酶抑制剂与血脑屏障中药物外排转运体相互作用的定量评估。
Pharm Res. 2005 Aug;22(8):1259-68. doi: 10.1007/s11095-005-5271-y. Epub 2005 Aug 3.
2',7'-双(2-羧乙基)-5(6)-羧基荧光素乙酰氧基甲酯(BCECF-AM)及其荧光游离酸BCECF的药物外排转运特性
J Pharm Sci. 2004 Apr;93(4):932-42. doi: 10.1002/jps.20018.
4
Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier.多药耐药相关蛋白1(Mrp1)参与17β-雌二醇-D-17β-葡萄糖醛酸苷(E217βG)跨血脑屏障的外排转运。
Pharm Res. 2003 Sep;20(9):1394-400. doi: 10.1023/a:1025749925541.
5
Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.在血脑屏障处表达的脑多药耐药蛋白(BMDP/ABCG2/BCRP)的特征
Brain Res. 2003 May 9;971(2):221-31. doi: 10.1016/s0006-8993(03)02401-6.
6
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.ATP结合盒(ABC)家族的哺乳动物药物外排转运蛋白:概述
Adv Drug Deliv Rev. 2003 Jan 21;55(1):3-29. doi: 10.1016/s0169-409x(02)00169-2.
7
Localisation of breast cancer resistance protein in microvessel endothelium of human brain.乳腺癌耐药蛋白在人脑微血管内皮中的定位。
Neuroreport. 2002 Nov 15;13(16):2059-63. doi: 10.1097/00001756-200211150-00014.
8
P-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs.癌细胞中P-糖蛋白的表达会影响六种化疗药物诱导的细胞毒性和细胞周期紊乱。
J Exp Ther Oncol. 2002 May-Jun;2(3):146-52. doi: 10.1046/j.1359-4117.2002.01010.x.
9
A new multidrug resistance protein at the blood-brain barrier.血脑屏障处一种新的多药耐药蛋白。
Biochem Biophys Res Commun. 2002 May 17;293(4):1273-8. doi: 10.1016/S0006-291X(02)00376-5.
10
In vitro P-glycoprotein affinity for atypical and conventional antipsychotics.体外P-糖蛋白对非典型和传统抗精神病药物的亲和力。
Life Sci. 2002 May 31;71(2):163-9. doi: 10.1016/s0024-3205(02)01680-6.